Similar Papers

Paper Title
Journal
Date
Author
Assessing cultural and linguistic diversity and distress screening completion in gynecologic oncology patients (iCALD)
Lawrence Kasherman ... Stephanie Lheureux
Gynecologic Oncology | VOL. 162
Lawrence Kasherman, et. al.Lawrence Kasherman ... Stephanie Lheureux
01 Aug 2021
Personalized survivorship care: Routine breast cancer risk assessment in the gynecologic oncology clinic
Muhammad Danyal Ahsan ... Melissa K Frey
Gynecologic Oncology | VOL. 183
Muhammad Danyal Ahsan, et. al.Muhammad Danyal Ahsan ... Melissa K Frey
18 Mar 2024
Indirect effects of COVID-19 in referring women to gynecologic oncology, perinatology and gynecology clinics in Iran.
Zahra Khazaeipour ... Erfan Razavi
Archives of gynecology and obstetrics | VOL. 304
Zahra Khazaeipour, et. al.Zahra Khazaeipour ... Erfan Razavi
31 May 2021
Basic social resource needs screening in the gynecologic oncology clinic: a quality improvement initiative
Anna Louise Beavis ... Stephanie L Wethington
American Journal of Obstetrics and Gynecology | VOL. 223
Anna Louise Beavis, et. al.Anna Louise Beavis ... Stephanie L Wethington
17 May 2020
View more papers

More From: Gynecologic Oncology

Paper Title
Journal
Date
Author
Molecular classification of endometrial cancers (EC) and association with relapse-free survival (RFS) and overall survival (OS) outcomes: Ancillary analysis of GOG-0258.
Aine Clements ... Angeles Alvarez Secord
Gynecologic oncology | VOL. 193
Aine Clements, et. al.Aine Clements ... Angeles Alvarez Secord
23 Jan 2025
Pembrolizumab in microsatellite instability-high/mismatch repair deficient (MSI-H/dMMR) and non-MSI-H/non-dMMR advanced endometrial cancer: Phase 2 KEYNOTE-158 study results.
David M O'Malley ... Michele Maio
Gynecologic oncology | VOL. 193
David M O'Malley, et. al.David M O'Malley ... Michele Maio
22 Jan 2025
Not all uterine carcinosarcomas are created equal: Survival outcomes according to molecular characterization of uterine carcinosarcoma.
Michael D Toboni ... Nathaniel Jones
Gynecologic oncology | VOL. 193
Michael D Toboni, et. al.Michael D Toboni ... Nathaniel Jones
20 Jan 2025
Cost-effectiveness of an additional hysterectomy after initially conservative treatment for cervical adenocarcinoma in situ.
M Schaafsma ... N.E Van Trommel
Gynecologic oncology | VOL. 193
M Schaafsma, et. al.M Schaafsma ... N.E Van Trommel
17 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.